Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.

Date publication

décembre 2016

Journal

Annales d'endocrinologie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno

Tous les auteurs :
Balkau B, Halimi S, Blickle JF, Vergès B, Avignon A, Attali C, Chartier I, Amelineau E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27646493

Résumé

To describe the management of glucose-lowering agents in people with type 2 diabetes initially on oral monotherapy, cared for by French general practitioners, and to identify reasons underlying treatment non-intensification.

Mots clés

Administration, Oral, Adult, Aged, Aged, 80 and over, Attitude of Health Personnel, Diabetes Mellitus, Type 2, drug therapy, Dose-Response Relationship, Drug, Female, General Practitioners, psychology, Humans, Hypoglycemic Agents, administration & dosage, Male, Middle Aged, Motivation, Practice Patterns, Physicians', statistics & numerical data, Treatment Outcome

Référence

Ann. Endocrinol. (Paris). 2016 Dec;77(6):649-657